210 related articles for article (PubMed ID: 14572143)
21. Mutations in the genes encoding eukaryotic translation initiation factor 2B in Japanese patients with vanishing white matter disease.
Shimada S; Shimojima K; Sangu N; Hoshino A; Hachiya Y; Ohto T; Hashi Y; Nishida K; Mitani M; Kinjo S; Tsurusaki Y; Matsumoto N; Morimoto M; Yamamoto T
Brain Dev; 2015 Nov; 37(10):960-6. PubMed ID: 25843247
[TBL] [Abstract][Full Text] [Related]
22. Intra-familial phenotypic heterogeneity in adult onset vanishing white matter disease.
Damon-Perriere N; Menegon P; Olivier A; Boespflug-Tanguy O; Niel F; Creveaux I; Dousset V; Brochet B; Goizet C
Clin Neurol Neurosurg; 2008 Dec; 110(10):1068-71. PubMed ID: 18845387
[TBL] [Abstract][Full Text] [Related]
23. Vanishing white matter disease.
van der Knaap MS; Pronk JC; Scheper GC
Lancet Neurol; 2006 May; 5(5):413-23. PubMed ID: 16632312
[TBL] [Abstract][Full Text] [Related]
24. [Association between homozygous c.318A>GT mutation in exon 2 of the EIF2B5 gene and the infantile form of vanishing white matter leukoencephalopathy].
Esmer C; Blanco Hernández G; Saavedra Alanís V; Reyes Vaca JG; Bravo Oro A
Bol Med Hosp Infant Mex; 2017; 74(5):364-369. PubMed ID: 29382480
[TBL] [Abstract][Full Text] [Related]
25. Vanishing white matter disease presenting as opsoclonus myoclonus syndrome in childhood--a case report and review of the literature.
Klingelhoefer L; Misbahuddin A; Jawad T; Mellers J; Jarosz J; Weeks R; Ray Chaudhuri K
Pediatr Neurol; 2014 Jul; 51(1):157-64. PubMed ID: 24938145
[TBL] [Abstract][Full Text] [Related]
26. Peripheral neuropathy in vanishing white matter disease with a novel EIF2B5 mutation.
Federico A; Scali O; Stromillo ML; Di Perri C; Bianchi S; Sicurelli F; De Stefano N; Malandrini A; Dotti MT
Neurology; 2006 Jul; 67(2):353-5. PubMed ID: 16864840
[TBL] [Abstract][Full Text] [Related]
27. Vanishing white matter disease with a novel EIF2B5 mutation: A 10-year follow-up.
Bektaş G; Yeşil G; Özkan MU; Yıldız EP; Uzunhan TA; Çalışkan M
Clin Neurol Neurosurg; 2018 Aug; 171():190-193. PubMed ID: 29933199
[TBL] [Abstract][Full Text] [Related]
28. Leukoencephalopathy with vanishing white matter:: an adult onset case.
Biancheri R; Rossi A; Di Rocco M; Filocamo M; Pronk JC; van der Knaap MS; Tortori-Donati P
Neurology; 2003 Dec; 61(12):1818-9. PubMed ID: 14694060
[No Abstract] [Full Text] [Related]
29. Ovarioleukodystrophy due to EIF2B5 mutations.
Ibitoye RT; Renowden SA; Faulkner HJ; Scolding NJ; Rice CM
Pract Neurol; 2016 Dec; 16(6):496-499. PubMed ID: 27651498
[TBL] [Abstract][Full Text] [Related]
30. A mouse model for eukaryotic translation initiation factor 2B-leucodystrophy reveals abnormal development of brain white matter.
Geva M; Cabilly Y; Assaf Y; Mindroul N; Marom L; Raini G; Pinchasi D; Elroy-Stein O
Brain; 2010 Aug; 133(Pt 8):2448-61. PubMed ID: 20826436
[TBL] [Abstract][Full Text] [Related]
31. Glial pathology in a novel spontaneous mutant mouse of the Eif2b5 gene: a vanishing white matter disease model.
Terumitsu-Tsujita M; Kitaura H; Miura I; Kiyama Y; Goto F; Muraki Y; Ominato S; Hara N; Simankova A; Bizen N; Kashiwagi K; Ito T; Toyoshima Y; Kakita A; Manabe T; Wakana S; Takebayashi H; Igarashi H
J Neurochem; 2020 Jul; 154(1):25-40. PubMed ID: 31587290
[TBL] [Abstract][Full Text] [Related]
32. An eleven-year history of Vanishing White Matter Disease in an adult patient with no cognitive decline and
Trevisan L; Grazzini M; Cianflone A; Accogli A; Finocchi C; Capello E; Saitta L; Grandis M; Roccatagliata L; Mandich P
Neurocase; 2021 Dec; 27(6):452-456. PubMed ID: 34751098
[TBL] [Abstract][Full Text] [Related]
33. Vanishing white matter disease in French-Canadian patients from Quebec.
Robinson MÈ; Rossignol E; Brais B; Rouleau G; Arbour JF; Bernard G
Pediatr Neurol; 2014 Aug; 51(2):225-32. PubMed ID: 25079571
[TBL] [Abstract][Full Text] [Related]
34. [Eukaryotic translation initiation factor 2B and leukoencephalopathy with vanishing white matter].
Pan YX; Wu Y; Niu ZP; Jiang YW
Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 41(5):608-10. PubMed ID: 19829687
[TBL] [Abstract][Full Text] [Related]
35. The ovarioleukodystrophy.
Mathis S; Scheper GC; Baumann N; Petit E; Gil R; van der Knaap MS; Neau JP
Clin Neurol Neurosurg; 2008 Dec; 110(10):1035-7. PubMed ID: 18678442
[TBL] [Abstract][Full Text] [Related]
36. Biochemical effects of mutations in the gene encoding the alpha subunit of eukaryotic initiation factor (eIF) 2B associated with Vanishing White Matter disease.
Wortham NC; Proud CG
BMC Med Genet; 2015 Aug; 16():64. PubMed ID: 26285592
[TBL] [Abstract][Full Text] [Related]
37. Arg113His mutation in eIF2Bepsilon as cause of leukoencephalopathy in adults.
van der Knaap MS; Leegwater PA; van Berkel CG; Brenner C; Storey E; Di Rocco M; Salvi F; Pronk JC
Neurology; 2004 May; 62(9):1598-600. PubMed ID: 15136689
[TBL] [Abstract][Full Text] [Related]
38. The gene for leukoencephalopathy with vanishing white matter is located on chromosome 3q27.
Leegwater PA; Könst AA; Kuyt B; Sandkuijl LA; Naidu S; Oudejans CB; Schutgens RB; Pronk JC; van der Knaap MS
Am J Hum Genet; 1999 Sep; 65(3):728-34. PubMed ID: 10441579
[TBL] [Abstract][Full Text] [Related]
39. Vanishing white matter disease associated with progressive macrocephaly.
Pineda M; R-Palmero A; Baquero M; O'Callaghan M; Aracil A; van der Knaap M; Scheper GC
Neuropediatrics; 2008 Feb; 39(1):29-32. PubMed ID: 18504679
[TBL] [Abstract][Full Text] [Related]
40. [CACH/VWM syndrome and leucodystrophies related to EIF2B mutations].
Labauge P; Fogli A; Niel F; Rodriguez D; Boespflug-Tanguy O
Rev Neurol (Paris); 2007 Sep; 163(8-9):793-9. PubMed ID: 17878805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
